BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $438,000 | -98.7% | 3,180 | -98.7% | 0.00% | -98.5% |
Q3 2021 | $33,939,000 | +380.4% | 244,326 | +235.7% | 0.06% | +400.0% |
Q2 2021 | $7,065,000 | +78400.0% | 72,780 | +52639.1% | 0.01% | – |
Q1 2021 | $9,000 | -99.9% | 138 | -99.9% | 0.00% | -100.0% |
Q4 2020 | $9,036,000 | +34.5% | 105,422 | +2.0% | 0.02% | +12.5% |
Q3 2020 | $6,717,000 | +0.4% | 103,321 | +12.9% | 0.02% | -5.9% |
Q2 2020 | $6,689,000 | +66.7% | 91,498 | -0.2% | 0.02% | +70.0% |
Q2 2019 | $4,013,000 | -68.3% | 91,638 | -62.7% | 0.01% | -67.7% |
Q1 2019 | $12,649,000 | +1204.0% | 245,758 | +837.3% | 0.03% | +933.3% |
Q4 2018 | $970,000 | – | 26,220 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |